|
Volumn 26, Issue 3, 2005, Pages 737-744
|
Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1,3 BUTADIENE DERIVATIVE;
1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE;
ENZYME INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE;
NITRILE;
NITROBENZENE DERIVATIVE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SULFONAMIDE;
ARTICLE;
CELL CULTURE;
CELL PROLIFERATION;
DRUG EFFECT;
ENDOMETRIUM TUMOR;
FEMALE;
HUMAN;
PATHOLOGY;
SIGNAL TRANSDUCTION;
WESTERN BLOTTING;
BLOTTING, WESTERN;
BUTADIENES;
CELL PROLIFERATION;
CYCLOOXYGENASE INHIBITORS;
ENDOMETRIAL NEOPLASMS;
ENZYME INHIBITORS;
EXTRACELLULAR SIGNAL-REGULATED MAP KINASES;
FEMALE;
HUMANS;
MAP KINASE KINASE KINASES;
NITRILES;
NITROBENZENES;
SIGNAL TRANSDUCTION;
SULFONAMIDES;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
EID: 20344394455
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.26.3.737 Document Type: Article |
Times cited : (25)
|
References (0)
|